Yearly Archives: 2024

Minister Stephen Kinnock recently responded to a Parliamentary Question regarding pharmacy reimbursement. In his response, he stated that pharmacies were allowed to retain £850m medicine margin in the year 2023/24. The pharmacy funding settlement for 2022/23 and 2023/24 included an uplift to the Drug Tariff, as £100m in excess margin earned by the sector in [...]

The post Clarification regarding retained margin in 2023/24 appeared first on Community Pharmacy England.

Drug alert number: EL (24)A/50 Date issued: 23 October 2024 Bristol Laboratories Ltd. are recalling one batch of Phenobarbital Bristol Labs 15mg Tablets as a precautionary measure due to the potential of contamination of small metallic particles within the tablets. PL 17907/0175 DMRC Number: DMRC-32910584 SNOMED Code:21039211000001106 Batch No Expiry Date Pack Size First Distributed [...]

The post MHRA Class 2 Medicines Recall: Phenobarbital Bristol Labs 15mg Tablets (Bristol Laboratories Ltd) appeared first on Community Pharmacy England.

The Secretary of State for Health and Social Care has this week launched a national conversation on the NHS, seeking input and ideas to shape the future of a reformed health service. Patients, members of the public and anyone working in the NHS have been invited to submit their views and ideas via the change.nhs.uk portal. [...]

The post Secretary of State launches national conversation on health service appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (22/10/2024) announced the following list of price concessions for October 2024: Drug Pack size Price concession Agomelatine 25mg tablets 28 £13.50 Amitriptyline 50mg/5ml oral solution sugar free 150 [...]

The post October 2024 Price Concessions – 2nd Update appeared first on Community Pharmacy England.